USANA Health Sciences Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
USANA Health Sciences (USNA) Misses Q2 EPS by 17c; Lowers Outlook, $100M Buyback
July 25, 2017 4:19 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.98, $0.17 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $257.1 million versus the consensus estimate of $284.44 million.
GUIDANCE:
USANA Health Sciences sees FY2017 EPS of $3.50-$3.70, versus the... More
